For over 20 years medical professionals have trusted Integra’s Dermal Regeneration Matrix (DRM) Technology to treat the most challenging wounds. The DRM Technology has been evaluated in four clinical trials involving 444 patients and has a long history of safe, effective use treating patients with third degree burns, scar reconstruction, and acute and chronic wounds in the operating room.
Now this powerful, proven solution is available in the outpatient setting to treat patients with diabetic foot ulcers.
The ONLY FDA approved product to regenerate native dermal tissue.
Based on DRM technology, Omnigraft is an advanced bilayer dermal regeneration matrix indicated for the treatment of diabetic foot ulcers.